title: Genomic Testing for Gemcitabine-Based Treatment of Pancreatic Cancer.
authors: Department of Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY (JZ, SNH).
authors: Jianliang
authors: J
authors: Zhang
authors: Department of Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY (JZ, SNH). steven.hochwald@roswellpark.org.
authors: Steven N
authors: SN
authors: Hochwald
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000401:mortality*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics*; D021441:Carcinoma, Pancreatic Ductal / Q000235:genetics* / Q000401:mortality*; D005260:Female; D006801:Humans; D008297:Male; D010088:Oxidoreductases / Q000235:genetics*; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000401:mortality*; D020641:Polymorphism, Single Nucleotide; D051703:Sp Transcription Factors / Q000235:genetics*; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D051703:Sp Transcription Factors; D025521:Tumor Suppressor Proteins; D010088:Oxidoreductases